Pictorial Warning Labels & Memory for Relative & Absolute Cigarette Health-risk Information Over Time in Adult Smokers

NCT03499340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3213

Last updated 2018-04-17

No results posted yet for this study

Summary

Pictorial cigarette warning labels (PWLs) are thought to increase risk knowledge, but experimental research has not examined PWLs' longer term effects on memory for health risks. In this study, adult smokers are repeatedly exposed to text-only vs. low arousal graphic vs. high arousal graphic warning labels paired with numeric risk information. This study will allow the investigators to assess the extent to which reactions to warnings remain consistent over time and influence smoking risk perceptions and quit intentions. The investigators will also assess the impact of graphic images on memory for smoking risk information presented in absolute (a smoker's lifetime risk of getting a smoking related disease) versus relative (a smoker's risk of getting a smoking related disease, compared to the risk of non-smokers) formats.

Conditions

  • Smoking Cessation
  • Smoking, Cigarette

Interventions

BEHAVIORAL

text-only PWL

control condition (no image)

BEHAVIORAL

low arousal graphic PWL

pictorial warning

BEHAVIORAL

high arousal graphic PWL

pictorial warning

BEHAVIORAL

absolute risk

Percentage risk information for smoking-related diseases for smokers

BEHAVIORAL

relative risk

Percentage risk information for smoking-related diseases for smokers and non-smokers

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-10
Primary Completion
2017-10-03
Completion
2017-10-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499340 on ClinicalTrials.gov